84612-076 : Wezlana 45 mg/.5ml Subcutaneous Injection, Solution


NDC: 84612-076
Labeler: Optum Health Solutions (Ireland) Limited
Product Type: Human Prescription Drug
Drug Name:  Wezlana
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761285
Rev. Date: 


NDC Package Codes:

  • 84612-076-01: 1 SYRINGE IN 1 CARTON (84612‑076‑01) / .5 ML IN 1 SYRINGE

Active Ingredients:

  • Ustekinumab

Dosage Strength:

  • 45 mg/.5mL

Pharmaceutical Classes:

  • Interleukin-12 Antagonist [EPC]
  • Interleukin-12 Antagonists [MoA]
  • Interleukin-23 Antagonist [EPC]
  • Interleukin-23 Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 84612-055 Wezlana 45 mg/.5ml Subcutaneous Injection, Solution by Optum Health Solutions (Ireland) Limited
  • 84612-066 Wezlana 130 mg/26ml Intravenous Injection, Solution by Optum Health Solutions (Ireland) Limited
  • 84612-089 Wezlana 90 mg/ml Subcutaneous Injection, Solution by Optum Health Solutions (Ireland) Limited
  • 84612-855 Wezlana 45 mg/.5ml Subcutaneous Injection, Solution by Optum Health Solutions (Ireland) Limited
  • 84612-876 Wezlana 45 mg/.5ml Subcutaneous Injection, Solution by Optum Health Solutions (Ireland) Limited
  • 84612-889 Wezlana 90 mg/ml Subcutaneous Injection, Solution by Optum Health Solutions (Ireland) Limited

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 84612-076 QR Code

< Prev: 84612-066Next: 84612-089 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.